![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07K 16/28 | (2006.01) |
A61K 39/395 | (2006.01) | ||
A61P 35/00 | (2006.01) |
(11) | Number of the document | 3313884 |
(13) | Kind of document | T |
(96) | European patent application number | 16736718.4 |
Date of filing the European patent application | 2016-06-28 | |
(97) | Date of publication of the European application | 2018-05-02 |
(45) | Date of publication and mention of the grant of the patent | 2020-11-18 |
(46) | Date of publication of the claims translation | 2021-03-10 |
(86) | Number | PCT/US2016/039797 |
Date | 2016-06-28 |
(87) | Number | WO 2017/004026 |
Date | 2017-01-05 |
(30) | Number | Date | Country code |
201562186161 P | 2015-06-29 | US | |
201662338203 P | 2016-05-18 | US | |
201662346730 P | 2016-06-07 | US |
(72) |
KOVTUN, Yelena, US
TAVARES, Daniel, US
RUI, Lingyun, US
CHITTENDEN, Thomas, US
|
(73) |
ImmunoGen, Inc.,
830 Winter Street, Waltham, MA 02451,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Anti-CD123 antikūnai, konjugatai ir jų dariniai |
ANTI-CD123 ANTIBODIES AND CONJUGATES AND DERIVATIVES THEREOF |
Payment date | Validity (years) | Amount | |
2025-05-09 | 10 | 231.00 EUR |
2026-06-28 |